The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ADMA BIOLOGICS INC | COM | 000899104 | 12,150 | 5,000,000 | SH | SOLE | 5,000,000 | 0 | 0 | ||
| AFFIMED NV | COM | N01045108 | 4,078 | 1,979,828 | SH | SOLE | 1,979,828 | 0 | 0 | ||
| AMARIN CORP PLC -ADR | SPONS ADR NEW | 023111206 | 9,317 | 8,547,965 | SH | SOLE | 8,547,965 | 0 | 0 | ||
| AMRYT PHARMA PLC - SPNR ADR | SPONSORED ADS | 03217L106 | 43,096 | 6,227,733 | SH | SOLE | 6,227,733 | 0 | 0 | ||
| APOLLO ENDOSURGERY INC | COM | 03767D108 | 15,608 | 2,832,631 | SH | SOLE | 2,832,631 | 0 | 0 | ||
| CONFORMIS INC | COM | 20717E101 | 3,309 | 17,304,350 | SH | SOLE | 17,304,350 | 0 | 0 | ||
| CTI BIOPHARMA CORP | COM | 12648L601 | 32,996 | 5,669,388 | SH | SOLE | 5,669,388 | 0 | 0 | ||
| EVOLUS INC | COM | 30052C107 | 1,610 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| LIGAND PHARMACEUTICALS | COM NEW | 53220K504 | 8,573 | 99,562 | SH | SOLE | 99,562 | 0 | 0 | ||
| ATYR PHARMA INC | COM NEW | 002120202 | 1,803 | 600,980 | SH | SOLE | 600,980 | 0 | 0 | ||
| OPIANT PHARMACEUTICALS INC | COM | 683750103 | 1,637 | 152,278 | SH | SOLE | 152,278 | 0 | 0 | ||
| OPTINOSE INC | COM | 68404V100 | 7,320 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
| OVID THERAPEUTICS INC | COM | 690469101 | 2,835 | 1,540,671 | SH | SOLE | 1,540,671 | 0 | 0 | ||
| QUIDELORTHO CORP | COM | 219798105 | 35,857 | 501,633 | SH | SOLE | 501,633 | 0 | 0 | ||
| REZOLUTE INC | COM NEW | 76200L309 | 8,147 | 2,973,205 | SH | SOLE | 2,973,205 | 0 | 0 | ||
| UROGEN PHARMA LTD | COM | M96088105 | 9,354 | 1,124,220 | SH | SOLE | 1,124,220 | 0 | 0 | ||
| XERIS BIOPHARMA HOLDINGS INC | COM | 98422E103 | 20,168 | 12,928,168 | SH | SOLE | 12,928,168 | 0 | 0 | ||
| EXAGEN INC | COM | 30068X103 | 3,429 | 1,265,373 | SH | SOLE | 1,265,373 | 0 | 0 | ||
| XOMA CORP | COM NEW | 98419J206 | 1,154 | 64,459 | SH | SOLE | 64,459 | 0 | 0 | ||